Europe Gene Amplification Technologies Market Size & Outlook
Related Markets
Europe gene amplification technologies market highlights
- The Europe gene amplification technologies market generated a revenue of USD 9,322.6 million in 2021.
- The market is expected to grow at a CAGR of -1.3% from 2022 to 2028.
- In terms of segment, pcr-based amplification was the largest revenue generating technology in 2021.
- Loop Mediated Isothermal Amplification (LAMP) is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2022 to 2028.
Europe data book summary
| Market revenue in 2021 | USD 9,322.6 million |
| Market revenue in 2028 | USD 8,525.9 million |
| Growth rate | -1.3% (CAGR from 2021 to 2028) |
| Largest segment | Pcr-based amplification |
| Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
| Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.0% of the global gene amplification technologies market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,409.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Amplification Technologies Market Scope
Gene Amplification Technologies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MyBiosource | View profile | 11-50 | San Diego, California, United States, North America | https://www.mybiosource.com/ |
| Vazyme Biotech | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | http://www.vazymebiotech.com/ |
| 4Basebio | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | https://www.4basebio.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| LGC Group | View profile | 1001-5000 | Teddington, Gloucestershire, United Kingdom, Europe | http://www.lgcgroup.com/ |
| Silicon Laboratories Inc | View profile | 1846 | 400 West Cesar Chavez, Austin, TX, United States, 78701 | https://www.silabs.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Europe gene amplification technologies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the Europe gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
Europe is second only to North America in the gene amplification technologies market. With the presence of international collaborations between European genomic institutes such as the European Molecular Biology Laboratory the European gene amplification technologies market is place is also expected to grow at a significant rate throughout the forecast period.
The rise in the adoption of various gene amplification technologies amongst end-users in Europe drives the market growth. In addition, growing investments for the development of new amplification technologies and active engagement of companies in extending product distribution across the globe in compliance with regulatory approvals are also contributing to regional market growth.
Reasons to subscribe to Europe gene amplification technologies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe gene amplification technologies market databook
-
Our clientele includes a mix of gene amplification technologies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe gene amplification technologies market , including forecasts for subscribers. This continent databook contains high-level insights into Europe gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe gene amplification technologies market size, by country, 2018-2028 (US$M)
Europe Gene Amplification Technologies Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
